Jun FANG
Associate professor
Email : fang.jun@sjtu.edu.cn
Office address : Wenxuan building 118, 800 Dongchuan RD. Minhang District, Shanghai, China 200240
Website : https://www.junfanglab.com/
Jun FANG
Associate professor
Email : fang.jun@sjtu.edu.cn
Office address : Wenxuan building 118, 800 Dongchuan RD. Minhang District, Shanghai, China 200240
Website : https://www.junfanglab.com/
Dr. Fang is an Associate Professor in the School of Biomedical Engineering at Shanghai Jiao Tong University since 2021. He received his PhD through a joint program supported by CSC Scholarship between Donghua University (State Key Laboratory for Modification of Chemical Fibers and Polymer Materials) and University of Pittsburgh in 2015. From 2016 to 2021, he was a Postdoctoral Research Fellow and an Assistant Project Scientist at the University of California, Los Angeles. Dr. Fang is the founding member and Associate Editor of the Med-X journal (ESCI). He has been awarded the Shanghai Overseas High-Level Talent Program and the Pujiang Talent Program. He also serves on several academic committees, including TIRMIS-AP, the Vascular Section of the Chinese Anatomical Society, and the Med-X International Academic Conference.
His research interests encompass biomaterials, stem cells and gene therapy, cardiovascular and skeletal muscle tissue repair and regeneration, as well as fundamental and translational research on disease therapy. He has published over 40 SCI-indexed papers in journals including Nat. Biomed. Eng., Nat. Nanotech., Nat. Commun., Adv. Funct. Mater., ACS Nano, and Research, holds multiple authorized Chinese and US patents, and has facilitated the translation of multiple research outcomes into clinical studies. He is hosting more than ten funded projects, including NSFC grants, Shanghai Municipal Science and Technology Commission projects, key/youth interdisciplinary projects, and industry-collaborative horizontal projects.
(1) Development and application of functionalized biomaterials;
(2) Stem cell and gene therapy for cardiovascular and muscular diseases;
(3) Immunoengineering and immunotherapy;
(4) Tissue engineering and regenerative medicine.